Finance

Beta
Lists
LABT:NASDAQ
Lakewood-amedex Biotherapeutics Inc
$0.76
0.00%
(0.00) 1D
$0.74
-2.46% (-0.019)
Pre-market
Closed: Jun 10, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LABT...
Mkt. cap
10.87M
Avg. vol.
3.24M
Volume
7.01K
52-wk high
$9.82
52-wk low
$0.59
EPS
-$0.27
No. of employees
5
Mkt. cap
10.87M
Avg. vol.
3.24M
Volume
7.01K
52-wk high
$9.82
52-wk low
$0.59
EPS
-$0.27
No. of employees
5
News stories
From sources across the web
About Lakewood-amedex Biotherapeutics Inc
CEO-
Employees5
Founded2006
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
169.80K
146.90K
752.93K
185.73K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
371.65K
489.32K
1.13M
525.17K
Operating expense
542.61K
637.38K
1.88M
712.06K
Total operating expenses
542.61K
637.38K
1.88M
712.06K
Operating income
-542.61K
-637.38K
-1.88M
-712.06K
Other non operating income
-
-
-
-
EBT including unusual items
-539.62K
-655.94K
-1.91M
-744.92K
EBT excluding unusual items
-539.62K
-655.94K
-1.91M
-744.92K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-539.62K
-655.94K
-1.91M
-744.92K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
4.31K
5.39K
10.97K
4.95K
Interest expense
-1.32K
-23.95K
-37.81K
-37.81K
Net interest expenses
2.99K
-18.56K
-26.84K
-32.86K
Depreciation and amortization charges
1.16K
1.16K
1.16K
1.16K
EBITDA
-541.45K
-636.23K
-1.88M
-710.90K
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more